CTOs on the Move


 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Secret Harbor

Secret Harbor is a Burlington, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Shepeard Community Blood Ctr

Shepeard Community Blood Ctr is a Augusta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Transcarent

Transcarent is a new consumer-directed health and care platform for employees of self-insured employers and their families. Using a combination of software, technology, Health Guides and data science, Transcarent empowers consumers with unbiased information, trusted guidance and access to high-value care.

PrimeMyBody

PrimeMyBody is a global company that helps people to live wellness and create lifestyle. We formulate life-changing products with quality in mind, and that means using nothing but the best nature has to offer. Being healthy isn`t a fad or a trend... instead, it`s a lifestyle, and our goal is to show the world just that.